Role of Sp1 in the Induction of p27 Gene Expression in Vascular Smooth Muscle Cells In Vitro and After Balloon Angioplasty

Abstract —The abnormal proliferation of vascular smooth muscle cells (VSMCs) plays an important role in atherosclerosis and restenosis. Although several studies have implicated the growth inhibitory protein p27Kip1 (p27) in the control of myocyte growth and hypertrophy, little is known about the molecular mechanisms that regulate p27 expression in the cardiovascular system. In the present study, we demonstrate the interaction of the transcription factor Sp1 with 2 GC-rich sequences within the p27 promoter in cultured VSMCs. Importantly, point mutations that disrupted Sp1 binding markedly reduced p27 promoter activity, demonstrating that Sp1 is required for efficient p27 gene transcription in cultured VSMCs. Because p27 expression is upregulated after balloon angioplasty, we investigated Sp1 expression and activity in control and balloon-injured rat carotid arteries to assess the role of Sp1 as a physiological regulator of p27 expression. Although immunohistochemical analysis disclosed Sp1 protein expression in both control and balloon-injured arteries, a high level of Sp1 DNA-binding activity was found only in response to balloon angioplasty. Collectively, these results demonstrate that Sp1 is essential for maximum p27 promoter activity in VSMCs and suggest that posttranslational induction of Sp1 DNA-binding activity contributes to the induction of p27 expression and VSMC growth arrest at late time points after balloon angioplasty.

[1]  A. Diez-Juan,et al.  Control of vascular smooth muscle cell growth by cyclin-dependent kinase inhibitory proteins and its implication in cardiovascular disease. , 2000, Frontiers in bioscience : a journal and virtual library.

[2]  S. Meloche,et al.  Differential regulation of p27(Kip1) expression by mitogenic and hypertrophic factors: Involvement of transcriptional and posttranscriptional mechanisms. , 2000, The Journal of cell biology.

[3]  P. V. van Diest,et al.  Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases. , 2000, The American journal of pathology.

[4]  T. Sakai,et al.  Sp1 and NF-Y Synergistically Mediate the Effect of Vitamin D3 in the p27Kip1 Gene Promoter That Lacks Vitamin D Response Elements* , 1999, The Journal of Biological Chemistry.

[5]  M. Mann,et al.  A novel role for the cyclin-dependent kinase inhibitor p27(Kip1) in angiotensin II-stimulated vascular smooth muscle cell hypertrophy. , 1999, The Journal of clinical investigation.

[6]  G. Brooks,et al.  Altered expression of cell cycle proteins and prolonged duration of cardiac myocyte hyperplasia in p27KIP1 knockout mice. , 1999, Circulation research.

[7]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[8]  M. Dickman,et al.  The Mycotoxin Fumonisin B1 Transcriptionally Activates the p21 Promoter through acis-Acting Element Containing Two Sp1 Binding Sites* , 1999, The Journal of Biological Chemistry.

[9]  A. Moustakas,et al.  Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[10]  V. Andrés,et al.  Role of c-fos and E2F in the induction of cyclin A transcription and vascular smooth muscle cell proliferation. , 1998, The Journal of clinical investigation.

[11]  E. Nabel,et al.  Expression of cyclin-dependent kinase inhibitors in vascular disease. , 1998, Circulation research.

[12]  S. C. Lin,et al.  Molecular characterization of the cyclin-dependent kinase inhibitor p27 promoter. , 1997, Biochimica et biophysica acta.

[13]  J. Isner,et al.  The biology of restenosis. , 1997, Progress in cardiovascular diseases.

[14]  P. Libby,et al.  The molecular bases of restenosis. , 1997, Progress in cardiovascular diseases.

[15]  E. Ziff,et al.  Nerve Growth Factor Induces Transcription of the p21 WAF1/CIP1 and Cyclin D1 Genes in PC12 Cells by Activating the Sp1 Transcription Factor , 1997, The Journal of Neuroscience.

[16]  P. Nisen,et al.  Downregulation of cyclin-dependent kinase 2 activity and cyclin A promoter activity in vascular smooth muscle cells by p27(KIP1), an inhibitor of neointima formation in the rat carotid artery. , 1997, The Journal of clinical investigation.

[17]  A. Takeshita,et al.  Adenovirus‐Mediated Transfer of Cyclin‐dependent Kinase Inhibitor‐p21 Suppresses Neointimal Formation in the Balloon‐Injured Rat Carotid Arteries in Vivo a , 1997, Annals of the New York Academy of Sciences.

[18]  K. Walsh,et al.  Temporally and spatially coordinated expression of cell cycle regulatory factors after angioplasty. , 1997, Circulation research.

[19]  M. Loda,et al.  Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas , 1997, Nature Medicine.

[20]  Herman Yeger,et al.  Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancer , 1997, Nature Medicine.

[21]  James M. Roberts,et al.  Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients , 1997, Nature Medicine.

[22]  James M. Roberts,et al.  Fibrillar Collagen Inhibits Arterial Smooth Muscle Proliferation through Regulation of Cdk2 Inhibitors , 1996, Cell.

[23]  E. Nabel,et al.  Role of the p21 cyclin-dependent kinase inhibitor in limiting intimal cell proliferation in response to arterial injury. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. Biggs,et al.  The Role of the Transcription Factor Sp1 in Regulating the Expression of the WAF1/CIP1 Gene in U937 Leukemic Cells (*) , 1996, The Journal of Biological Chemistry.

[25]  Xiao-Fan Wang,et al.  Functional Analysis of the Transforming Growth Factor βResponsive Elements in the WAF1/Cip1/p21 Promoter (*) , 1995, The Journal of Biological Chemistry.

[26]  J. Leiden,et al.  Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty. , 1995, The Journal of clinical investigation.

[27]  K. Walsh,et al.  Regulation of Gax homeobox gene transcription by a combination of positive factors including myocyte-specific enhancer factor 2 , 1995, Molecular and cellular biology.

[28]  David O. Morgan,et al.  Principles of CDK regulation , 1995, Nature.

[29]  Paul Nurse,et al.  Ordering S phase and M phase in the cell cycle , 1994, Cell.

[30]  C. Sherr G1 phase progression: Cycling on cue , 1994, Cell.

[31]  J. Miano,et al.  Localization of Fos and Jun proteins in rat aortic smooth muscle cells after vascular injury. , 1993, The American journal of pathology.

[32]  J. Miano,et al.  Early proto-oncogene expression in rat aortic smooth muscle cells following endothelial removal. , 1990, The American journal of pathology.

[33]  K. Karsch,et al.  Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty. , 1990, Circulation research.

[34]  H. Harris,et al.  Expression of a human placental alkaline phosphatase gene in transfected cells: use as a reporter for studies of gene expression. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[35]  M. Reidy,et al.  Kinetics of cellular proliferation after arterial injury. III. Endothelial and smooth muscle growth in chronically denuded vessels. , 1986, Laboratory investigation; a journal of technical methods and pathology.

[36]  S. Schwartz,et al.  Significance of Quiescent Smooth Muscle Migration in the Injured Rat Carotid Artery , 1985, Circulation research.

[37]  M. Reidy,et al.  Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[38]  J. Rowe,et al.  Vascular smooth muscle cell growth kinetics in vivo in aged rats. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[39]  M. Adams,et al.  Time course of cellular proliferation, intimal hyperplasia, and remodeling following angioplasty in monkeys with established atherosclerosis. A nonhuman primate model of restenosis. , 1996, Arteriosclerosis, thrombosis, and vascular biology.